StockData
TherapeuticsMD, Inc. logo

TherapeuticsMD, Inc. (TXMD) stock

TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 12/3026% below fair value
$1.91+0.10 (+5.52%)

Close on Nov 17, 2026Market cap $22.11MP/E –Yield –

TherapeuticsMD market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

TherapeuticsMD's market cap was $21.41M on Nov 11, 2026, against $19.68M a year earlier. Over the last 5 years it ranged from $9.92M to $163.36M, with a median of $25.00M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$21.41M+13.5%
2025Dec 31, 2025$18.87M+90.2%
2024Dec 31, 2024$9.92M-58.3%
2023Dec 29, 2023$23.79M-55.0%
2022Dec 30, 2022$52.92M-65.4%
2021Dec 31, 2021$152.96M-53.7%
2020Dec 31, 2020$330.10M-43.5%
2019Dec 31, 2019$583.89M-35.2%
2018Dec 31, 2018$900.93M-31.1%
2017Dec 29, 2017$1.31B+15.2%
2016Dec 30, 2016$1.13B-38.5%
2015Dec 31, 2015$1.84B+165.5%
2014Dec 31, 2014$694.34M-8.1%
2013Dec 31, 2013$755.26M+209.9%
2012Dec 31, 2012$243.68M+177.4%
2011Dec 30, 2011$87.86M–

More TherapeuticsMD figures

See a number that looks wrong?